Abnormal TRPM8 expression gradients have been observed in precancerous pancreatic tissues and malignant tumors, with most pancreatic cancers depicting moderate-to-high TRPM8 levels and a positive correlation noted between anti-TRPM8 immunoreactivity and primary tumor size and stage. The gene discussed is TRPM8; the disease is pancreatic neoplasm.